{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome d'hypertension intracrânienne bénigne : Questions médicales les plus fréquentes",
"headline": "Syndrome d'hypertension intracrânienne bénigne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome d'hypertension intracrânienne bénigne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-18",
"dateModified": "2026-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome d'hypertension intracrânienne bénigne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypertension intracrânienne",
"url": "https://questionsmedicales.fr/mesh/D019586",
"about": {
"@type": "MedicalCondition",
"name": "Hypertension intracrânienne",
"code": {
"@type": "MedicalCode",
"code": "D019586",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.631"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome d'hypertension intracrânienne bénigne",
"alternateName": "Pseudotumor Cerebri",
"code": {
"@type": "MedicalCode",
"code": "D011559",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Muhammad Mahajnah",
"url": "https://questionsmedicales.fr/author/Muhammad%20Mahajnah",
"affiliation": {
"@type": "Organization",
"name": "Child Neurology and Development Center (MM, ATS, HZ, SSR), Hillel-Yaffe Medical Center, Hadera, Israel ; Child Neurology Unit (JG), Bnai-Zion Medical Center, Haifa, Israel ; Pediatric Department (IS, JG), Bnai-Zion Medical Center, Haifa, Israel ; The Ruth and Bruce Rappaport Faculty of Medicine (MM, IS, JG), Technion, Haifa, Israel ; The Triangle Regional Research and Development Center (RS), Kfar Qara, Israel ; and Beit Berl Academic College (RS), Israel."
}
},
{
"@type": "Person",
"name": "Jacob Genizi",
"url": "https://questionsmedicales.fr/author/Jacob%20Genizi",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Grant T Liu",
"url": "https://questionsmedicales.fr/author/Grant%20T%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Neuro-ophthalmology Service, Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, PA, United States."
}
},
{
"@type": "Person",
"name": "Kathleen B Digre",
"url": "https://questionsmedicales.fr/author/Kathleen%20B%20Digre",
"affiliation": {
"@type": "Organization",
"name": "John A. Moran Eye Center, University of Utah, Salt Lake City, Utah."
}
},
{
"@type": "Person",
"name": "Deborah I Friedman",
"url": "https://questionsmedicales.fr/author/Deborah%20I%20Friedman",
"affiliation": {
"@type": "Organization",
"name": "Yellow Rose Headache and Neuro-Ophthalmology. Electronic address: DeborahFriedman@tx.rr.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The relationship between body mass index and cerebrospinal fluid pressure in children with pseudotumor cerebri.",
"datePublished": "2024-08-17",
"url": "https://questionsmedicales.fr/article/39154176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13052-024-01722-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "From Pseudotumor Cerebri to Neurobrucellosis: A Journey With Several Lessons.",
"datePublished": "2024-04-03",
"url": "https://questionsmedicales.fr/article/38707027",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.57496"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pseudotumor cerebri in the paediatric population: clinical features, treatment and prognosis.",
"datePublished": "2024-01-23",
"url": "https://questionsmedicales.fr/article/38272258",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nrleng.2024.01.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Frontonasal Encephalocele Complicated With Pseudotumor Cerebri: A Case Report and Literature Review.",
"datePublished": "2023-09-18",
"url": "https://questionsmedicales.fr/article/37868498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.45509"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy and Side Effects of Topiramate in Treatment of Children With Pseudotumor Cerebri Syndrome.",
"datePublished": "2024-07-08",
"url": "https://questionsmedicales.fr/article/39178652",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pediatrneurol.2024.06.015"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hypertension intracrânienne",
"item": "https://questionsmedicales.fr/mesh/D019586"
},
{
"@type": "ListItem",
"position": 6,
"name": "Syndrome d'hypertension intracrânienne bénigne",
"item": "https://questionsmedicales.fr/mesh/D011559"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome d'hypertension intracrânienne bénigne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome d'hypertension intracrânienne bénigne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome d'hypertension intracrânienne bénigne",
"description": "Comment diagnostique-t-on le syndrome d'hypertension intracrânienne bénigne ?\nQuels examens sont nécessaires pour confirmer le diagnostic ?\nQuels signes cliniques indiquent ce syndrome ?\nLe syndrome peut-il être confondu avec d'autres conditions ?\nQuel rôle joue la ponction lombaire dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D011559#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome d'hypertension intracrânienne bénigne",
"description": "Quels sont les symptômes principaux du syndrome ?\nLes troubles visuels sont-ils fréquents ?\nComment les maux de tête se manifestent-ils ?\nY a-t-il des symptômes associés à la pression intracrânienne ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D011559#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome d'hypertension intracrânienne bénigne",
"description": "Peut-on prévenir le syndrome d'hypertension intracrânienne ?\nQuels conseils pour éviter l'aggravation des symptômes ?\nLe suivi médical est-il important ?\nLes femmes enceintes doivent-elles être surveillées ?\nY a-t-il des activités à éviter ?",
"url": "https://questionsmedicales.fr/mesh/D011559#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome d'hypertension intracrânienne bénigne",
"description": "Quels traitements sont disponibles pour ce syndrome ?\nLes diurétiques sont-ils efficaces ?\nQuand la chirurgie est-elle envisagée ?\nY a-t-il des traitements non médicamenteux ?\nLes corticostéroïdes sont-ils utilisés ?",
"url": "https://questionsmedicales.fr/mesh/D011559#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome d'hypertension intracrânienne bénigne",
"description": "Quelles complications peuvent survenir ?\nLa perte de vision est-elle réversible ?\nLe syndrome peut-il entraîner des problèmes cognitifs ?\nLes complications sont-elles fréquentes ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D011559#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome d'hypertension intracrânienne bénigne",
"description": "Quels sont les principaux facteurs de risque ?\nLes femmes sont-elles plus à risque ?\nLes médicaments peuvent-ils influencer le risque ?\nLe surpoids est-il un facteur de risque ?\nY a-t-il des facteurs génétiques impliqués ?",
"url": "https://questionsmedicales.fr/mesh/D011559#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome d'hypertension intracrânienne bénigne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie cérébrale et la ponction lombaire."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une IRM cérébrale et une évaluation de la pression du liquide céphalorachidien sont essentielles."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des maux de tête, des troubles visuels et des acouphènes."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il être confondu avec d'autres conditions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des tumeurs cérébrales ou des méningites."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la ponction lombaire dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de mesurer la pression intracrânienne et d'analyser le liquide céphalorachidien."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les troubles visuels sont-ils fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la vision floue ou des scotomes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les maux de tête se manifestent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent pulsants et peuvent s'aggraver en position couchée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à la pression intracrânienne ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des acouphènes et des vertiges peuvent également apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le syndrome d'hypertension intracrânienne ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un poids santé peut aider."
}
},
{
"@type": "Question",
"name": "Quels conseils pour éviter l'aggravation des symptômes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments riches en sel et maintenir une hydratation adéquate sont conseillés."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet de surveiller l'évolution et d'ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes sont à risque accru et doivent être suivies de près."
}
},
{
"@type": "Question",
"name": "Y a-t-il des activités à éviter ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les activités à fort impact sur la tête ou le cou doivent être évitées pour prévenir les symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ce syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments comme les diurétiques et, dans certains cas, la chirurgie."
}
},
{
"@type": "Question",
"name": "Les diurétiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à réduire la pression intracrânienne en diminuant le volume de liquide céphalorachidien."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle envisagée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si les traitements médicaux échouent ou en cas de perte de vision."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte de poids et la réduction de la consommation de sel peuvent aider."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être utilisés dans certains cas pour réduire l'inflammation et la pression."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision permanente et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La perte de vision est-elle réversible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la rapidité du traitement; une intervention précoce peut aider."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il entraîner des problèmes cognitifs ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir en raison de la pression intracrânienne élevée."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont pas fréquentes si le syndrome est bien géré, mais un suivi est crucial."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement approprié et un suivi régulier sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, les troubles hormonaux et certains médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes, en particulier celles en âge de procréer, sont plus souvent touchées."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments comme les stéroïdes peuvent augmenter le risque d'hypertension intracrânienne."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids est un facteur de risque majeur pour le développement de ce syndrome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs génétiques impliqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux peuvent jouer un rôle, mais les recherches sont encore en cours."
}
}
]
}
]
}
Child Neurology and Development Center (MM, ATS, HZ, SSR), Hillel-Yaffe Medical Center, Hadera, Israel ; Child Neurology Unit (JG), Bnai-Zion Medical Center, Haifa, Israel ; Pediatric Department (IS, JG), Bnai-Zion Medical Center, Haifa, Israel ; The Ruth and Bruce Rappaport Faculty of Medicine (MM, IS, JG), Technion, Haifa, Israel ; The Triangle Regional Research and Development Center (RS), Kfar Qara, Israel ; and Beit Berl Academic College (RS), Israel.
Publications dans "Syndrome d'hypertension intracrânienne bénigne" :
Pediatric Headache Program, Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Szperka@email.chop.edu.
Department of Neurology, Perelman School of Medicine, University of Pennsylvania, CTRB 10019 3501 Civic Center Blvd., Philadelphia, PA, 19104, USA. Szperka@email.chop.edu.
Publications dans "Syndrome d'hypertension intracrânienne bénigne" :
Department of Ophthalmology, Baylor College of Medicine, Houston, Texas.
Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Department of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Department of Ophthalmology, University of Cincinnati, Cincinnati, Ohio.
Publications dans "Syndrome d'hypertension intracrânienne bénigne" :
Childhood obesity has become a major global health problem. Obesity is associated with major health problems, such as diabetes, hypertension, dyslipidemia, cardiovascular disease. Obesity is also cons...
A total of 48 children diagnosed with PTC, who were aged < 18 years and followed up in the pediatric clinic were included in the retrospective study. National BMI percentile curves were used for refer...
Of total patients 27 were female (56.25%) and 21 were male (43.75%). With regard to the BMI percentile, 20 (41.67%) were overweight or obese. CSF pressure was higher in overweight and obese patients c...
The results of the present study indicate a direct relationship between CSF pressure and BMI in children with PTC. Appropriate diet, exercise, and medical treatment in overweight and obese children ca...
We present a case admitted for evaluation of suspected idiopathic intracranial hypertension (IIH) with an unusual but important departure from the expected algorithm. A 31-year-old lady came with a tw...
Pseudotumor cerebri (PC) in prepubertal patients displays certain characteristics that differentiate it from its presentation at the postpubertal stage. The aim of this study is to describe the charac...
We included patients aged between 1 and 18 years who were diagnosed with PC in a tertiary-level hospital between 2006 and 2019 and who met the updated diagnostic criteria for PC. They were classified ...
We included 28 patients, of whom 22 were of prepubertal age and 6 were of postpubertal age. The mean age (standard deviation) was 9.04 (2.86) years. Among the postpubertal patients, 83.3% were boys, 6...
Prepubertal patients with PC show lower prevalence of obesity, higher prevalence of secondary aetiologies, and higher recurrence rates than postpubertal patients....
Primary pseudotumor cerebri syndrome (PPTS) is a rare disorder of elevated intracranial pressure (ICP) in the absence of an identifiable underlying etiology. Afflicted patients are usually obese women...
Topiramate is often considered as a second-line medication for the treatment of pseudotumor cerebri syndrome (PTCS), but limited studies exist that evaluate its efficacy in children....
Retrospective study of patients aged <21 years with PTCS who were treated with topiramate alone or in combination with acetazolamide was performed. Data regarding clinical courses and visual outcomes ...
A total of 46 patients were identified. Three (6.5%) patients were treated with topiramate alone, 31 (67.4%) transitioned to topiramate from acetazolamide, and 12 (26.1%) took both topiramate and acet...
Topiramate can effectively treat PTCS in children with mild to moderate papilledema or in those unable to tolerate acetazolamide. More research is needed to assess the efficacy of topiramate for highe...
Pseudotumor cerebri (PTC) encompasses a constellation of symptoms caused by elevated intracranial pressure of unclear etiology. Various associations have been described, rarely hypovitaminosis D. Vita...
Pseudotumor cerebri (PTC) is a disorder characterized by increased intracranial pressure in the absence of a structural lesion or other identifiable cause. Cytokines, which are involved in the regulat...
This cross-sectional study aimed to report all neuroimaging findings suggestive of raised intracranial pressure in children with pseudotumor cerebri syndrome (PTCS), before and after re-review by two ...
We included 48 children aged <18 years diagnosed with PTCS between 2016 and 2021. Clinical and radiological data were obtained from their medical files. Two neuroradiologists independently re-reviewed...
The initial neuroimaging reports showed under-reporting of findings, with only 26 of 48 (54.1%) patients identified with abnormal reports. After revision, the proportion of the reported findings incre...
This study highlights the impact of image revision in enhancing PTCS diagnosis. Intra- and interclass correlations underscore the reliability of the review process, emphasizing the importance of metic...
Pseudotumor cerebri syndrome (PTC) is a chronic disorder, which is initially treated by conservative measures, yet surgery is inevitable in case of progressive worsening of vision or headache despite ...
This retrospective study included the patients with PTC who were operated by endoscopic optic nerve decompression (EOND), ventriculoperitoneal (VP) and lumboperitoneal (LP) shunting. Surgical outcomes...
Seventeen of 36 patients were treated with shunting, 14 with EOND and 5 patients with both EOND and shunting. No statistical significance was observed between CSF diversion procedures and EOND concern...
Our study demonstrated comparable results between shunting and EOND, regarding the efficacy on surgical outcomes. EOND is quite effective for headache besides its advantage on treatment-refractory vis...
Lymphomatosis cerebri (LC) is a rare manifestation of primary central nervous system lymphoma (PCNSL) with only a few cases reported in the literature, appearing as diffuse infiltrating process rather...
We intend to report this unique case of LC which came across as a diagnostic challenge....
A 53-year-old gentleman presented with complaints of two episodes of seizures 24 h apart followed by postictal confusion for 10-15 min. He underwent multiple MRI scans and underwent a biopsy of the le...
The imaging was reviewed, suspicion of LC was raised and a review of histopathology was requested which later confirmed primary CNS lymphoma....
LC is a rare but established manifestation of PCNSL which mimics multiple other conditions. Understanding of the imaging pattern is important in making the diagnosis and differentiating it from other ...